摘要
流行病学研究表明,恶性肿瘤患者发生心房颤动(房颤)的风险高于一般人群。相对于传统房颤的发病机制,合并恶性肿瘤的房颤存在一些与肿瘤环境及治疗相关的特殊机制。由于恶性肿瘤合并房颤患者的出血与栓塞风险难以平衡,如何处理合并恶性肿瘤的房颤已成为当前肿瘤心脏病学中的热点问题。本文主要就恶性肿瘤相关性房颤的流行病学、发病机制以及治疗等方面进行归纳探讨。
Many epidemiological studies have shown that the risk of atrial fibrillation(AF) in patients with malignant tumor is higher than that in the general population. Compared with the traditional pathogenesis of AF, AF with malignant tumor has some special mechanisms related to tumor environment and treatment. Because malignant tumor will increase the risk of thromboembolism and bleeding, it is difficult to balance the risk of embolism and bleeding in such patients. How to deal with AF patients with malignant tumor has become a hot issue in Oncocardiology. This article mainly discusses the epidemiology, pathogenesis and treatment of malignant tumor associated AF.
作者
陈雨卉
王运松
夏云龙
CHEN Yuhui;WANG Yunsong;XIA Yunlong(Department of Cardiology,The First Affiliated Hospital of Dalian Medical University,Dalian,Liaoning,116011,China)
出处
《临床心血管病杂志》
CAS
北大核心
2021年第2期177-181,共5页
Journal of Clinical Cardiology
关键词
恶性肿瘤
心房颤动
流行病学
neoplasms
atrial fibrillation
epidemiology
